InvestorsHub Logo
Followers 8
Posts 549
Boards Moderated 0
Alias Born 02/03/2017

Re: $Pistol Pete$ post# 2888

Thursday, 01/30/2020 12:27:30 PM

Thursday, January 30, 2020 12:27:30 PM

Post# of 3061

In connection with the Merger, BioPharmX intends to file a Form S-4 registration statement with the U.S. Securities and Exchange Commission (“SEC”) that will contain a prospectus to register the BioPharmX shares to be issued to Timber's members in the Merger and a proxy statement for use in connection with the special meeting of BioPharmX stockholders that will be called to consider and vote upon the Merger and related matters. Further, the Form S-4 registration statement will describe a proposed reverse stock split of the post-Merger outstanding common stock of BioPharmX (in a ratio to be determined), which shall also be subject to approval by the BioPharmX stockholders at the special stockholders' meeting.


Go to otcmarkets.com and search BPMX, click on “disclosure” and scroll down to the SEC filings from this week.... 8-k and 425. It’s all there.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.